Web5001 to 10000 Employees. Founded: 1996. Type: Company - Public (CPHD) Industry: Biotech & Pharmaceuticals. Revenue: $1 to $5 billion (USD) Cepheid’s GeneXpert® systems and Xpert® tests automate … WebCepheid Revenues from 2010 to 2024. Check Cepheid financial statements over time to gain insight into future company performance. You can evaluate financial statements to …
Did you know?
WebThe global point of care diagnostics market size was valued at USD 46.65 billion in 2024. The market is projected to grow from USD 36.37 billion in 2024 to USD 51.94 billion by 2029, exhibiting a CAGR of 5.2% during the forecast period. The global COVID-19 pandemic has been unprecedented and staggering, with experiencing higher-than … Web1 day ago · In terms of revenue, the global two largest companies occupied for a share nearly percent in 2024. Get a Sample Copy of the Blood Culture Test Devices Report 2024
WebCepheid operates as a molecular diagnostics company, which develops, manufactures, and markets fully-integrated systems for testing in the clinical market, WebCepheid, a molecular diagnostics company, develops, manufactures, and markets integrated systems for testing in the clinical and nonclinical markets. Instrument. USA Stock View All. Exchange. NASDAQ Exchange. Business Address. 904 Caribbean Drive, Benchmark. NYSE Composite.
Web2024 Annual Report. Financial Operating Highlights 2024 Segment Revenues Letter to Shareholders Life Sciences Diagnostics Environmental & Applied Solutions - Water Quality Environmental & Applied Solutions - Product Identification. Form 10- K: Part I. Form 10-K Information Relating to Forward-Looking Statements 1. Business 1A. WebApr 10, 2024 · Blood Glucose Test Strip Market 2024 Size, Statistics, Growth, Revenue, Analysis & Trends Industry Forecast Report -2025 Market Research Engine Apr 10, 2024
Web2 days ago · The research report on the Global Next Generation Cancer Diagnostic Devices Market includes a regional analysis of sales, revenue, market growth rate, and share in key regions from 2024 to 2030 ...
WebApr 11, 2024 · CEPHEID K101879: 07/28/2010 xpert mrsa/sa nasal assay: CEPHEID K100822: 06/01/2010 xpert mrsa/sa blood culture assay: CEPHEID K082140: 09/29/2008 xpert mrsa/sa ssti assay: CEPHEID K080837: 09/24/2008 xpert mrsa child care scholarship application marylandWebApr 10, 2024 · Blood Glucose Test Strip Market 2024 Size, Statistics, Growth, Revenue, Analysis & Trends Industry Forecast Report -2025 Market Research Engine Apr 10, 2024 got my hand in my pocketWebSee insights on Cepheid including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. childcare scheme my govWebCepheid Inc. Cepheid AB. Cepheid GmbH. Cepheid SA. SIC Code 38,382. NAICS Code 33,339. Show More. Top Competitors of Cepheid. Illumina Inc. 10,200. $4.6B. 1 . Myriad … got my hands fullCepheid is an American molecular diagnostics company. Its systems automate traditional nucleic acid tests (tests for specific sequences of DNA or RNA). The tests can be used to identify and analyze pathogens and genetic disorders. Cepheid sells clinical tests for healthcare-associated infections, infectious … See more Cepheid owns the GeneXpert rapid molecular diagnostic system, its main product. The system was developed in the 1990s; the design remained substantially the same from the turn of the century to 2024. Similar tests … See more There has been controversy around Cepheid's test-cartridge pricing. Cepheid announced that they would charge US$19.80 per COVID-19 test in developing countries (prices are higher in middle-income countries; for instance, GeneXpert TB tests … See more • GeneXpert MTB/RIF (the tuberculosis test) • Nucleic acid test (the technique automated by Cepheid) See more The key engineering innovations underlying GeneXpert technologies, as well as early versions of the product and field testing, were done at the Lawrence Livermore National Laboratory at the University of California. It was funded by the … See more Cepheid was founded in March 1996 by Thomas Gutshall, Bill McMillan, Dr. Kurt Petersen, Dr. Greg Kovacs, Steven Young and Dr. Allen Northrup. The company went … See more • ^[a] The legal name of the company is the single word Cepheid, with no indicator of corporate status in its name. This is legal in California. See more got my hands up playing my songWebFeb 25, 2016 · For the year ended December 31, 2015, Cepheid reported revenue of $538.6 million which compares to revenue of $470.1 million in 2014. Net loss for the year was $ (48.5) million, or $ (0.67) per share, which compares to net loss of $ (50.1) million, or $ (0.72) per share, in 2014. Excluding stock-based compensation expense, amortization … got my head around中文Web2 days ago · 4 Global Genomics Sales Volume and Revenue Region Wise (2024-2024) 4.1 Global Genomics Sales Volume and Market Share, Region Wise 4.2 Global Genomics Revenue and Market Share, Region Wise childcare scholarships